Hims & Hers Health Inc

HIMS

44.460USD

+2.930+7.06%

Close 09/03, 16:00（ET）Quotes delayed by 15 min

Score

Industry at a Glance

Industry Ranking

89 / 280

Overall Ranking

208 / 4737

Industry

Healthcare Services & Equipment

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 14 analysts

Hold

Current Rating

50.372

Target Price

+21.29%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 180.22% year-on-year.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD 126.04M.%!(EXTRA int=2)

Undervalued

The company’s latest PE is 50.42, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 201.00M shares, decreasing 14.69% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 18.63M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.72.

The company's current financial score is 7.60, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 586.01M, representing a year-over-year increase of 110.67%, while its net profit experienced a year-over-year increase of 344.69%.

Score

Industry at a Glance

Previous score

7.60

Change

0



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.03

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.51

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.40

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.08

Key Metrics

Free cash flow

No Data

The company’s current valuation score is 1.80, which is lower than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is 49.91, which is 39.64% below the recent high of 69.70 and -3.81% above the recent low of 51.81.

Score

Industry at a Glance

Previous score

1.80

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 89/280

No Data

The company’s current earnings forecast score is 6.43, which is lower than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Hims & Hers Health Inc is 48.00, with a high of 85.00 and a low of 28.00.

Score

Industry at a Glance

Previous score

6.43

Change

0

Support & Resistance

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The company’s current price momentum score is 6.91, which is lower than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 62.65 and the support level at 33.15, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.72

Change

0.4

Support & Resistance

No Data

Institutional Confidence

Currency: USD Updated：2025-09-03

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 92.37%, representing a quarter-over-quarter increase of 7.44%. The largest institutional shareholder is The Vanguard, holding a total of 18.63M shares, representing 8.56% of shares outstanding, with 10.04% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

21.80M

-21.10%

The Vanguard Group, Inc.

Star Investors

18.44M

-8.80%

Dudum (Andrew)

10.23M

+0.06%

Abraham (Jack)

9.32M

-21.93%

Farallon Capital Management, L.L.C.

7.95M

-5.05%

Goldman Sachs & Company, Inc.

7.72M

+48.65%

State Street Global Advisors (US)

7.44M

-4.24%

Renaissance Technologies LLC

Star Investors

7.02M

+1.05%



1

2



The company's beta value is 2.15. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Hims & Hers Health Inc

HIMS

6.19 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Insulet Corp

PODD

7.90 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Merit Medical Systems Inc

MMSI

7.75 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Brightspring Health Services Inc

BTSG

7.67 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Tenet Healthcare Corp

THC

7.67 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cencora Inc

COR

7.60 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.